ICICI Direct recommended hold rating on Dixon Technologies with a target price of Rs 4730 in its research report dated October 23, 2022.
Posts tagged MC
Hold Dixon Technologies; target of Rs 4730: ICICI Direct (26-10-2022)
Hold Dixon Technologies; target of Rs 4730: ICICI Direct (26-10-2022)
ICICI Direct recommended hold rating on Dixon Technologies with a target price of Rs 4730 in its research report dated October 23, 2022.
Hold Amber Enterprises; target of Rs 2395: ICICI Direct (26-10-2022)
ICICI Direct recommended hold rating on Amber Enterprises with a target price of Rs 2395 in its research report dated October 23, 2022.
Hold Amber Enterprises; target of Rs 2395: ICICI Direct (26-10-2022)
ICICI Direct recommended hold rating on Amber Enterprises with a target price of Rs 2395 in its research report dated October 23, 2022.
Hold Indraprastha Gas; target of Rs 430: ICICI Direct (26-10-2022)
ICICI Direct recommended hold rating on Indraprastha Gas with a target price of Rs 430 in its research report dated October 23, 2022.
Hold Indraprastha Gas; target of Rs 430: ICICI Direct (26-10-2022)
ICICI Direct recommended hold rating on Indraprastha Gas with a target price of Rs 430 in its research report dated October 23, 2022.
Buy Larsen and Toubro Finance Holdings; target of Rs 88: Prabhudas Lilladher (25-10-2022)
Prabhudas Lilladher is bullish on Larsen and Toubro Finance Holdings has recommended buy rating on the stock with a target price of Rs 88 in its research report dated October 25, 2022.
Buy Torrent Pharmaceuticals; target of Rs 1850: Prabhudas Lilladher (25-10-2022)
Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated October 25, 2022.
Buy Torrent Pharmaceuticals; target of Rs 1850: Prabhudas Lilladher (25-10-2022)
Prabhudas Lilladher is bullish on Torrent Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated October 25, 2022.
Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher (25-10-2022)
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated October 25, 2022.